CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider (Saxo Bank). You should consider whether you understand how CFDs, FX or any of our other products work and whether you can afford to take the high risk of losing your money.
GSK has reported its Q4 and FY2016 results today. The CEO has kept his promise on the dividend.
The GSK results were helped by the sterling devaluation however clouds on the horizon have emerged stateside.
We give a brief review of these results and comment on industry developments.
Read our Report
General Risk Warning
Trading in the products and services offered may result in losses as well as profits as the value of investments may go down as well as up. You may not get back the full amount you have invested. Any reference to past performance should not be viewed as an indication of any future performance. Investments held in overseas markets are subject to the effects of changes in exchange rates which will impact on the value of the underlying investment. Investments made in AIM and penny shares carry an increased risk due to the difficulty in creating a market in these shares. There may be a substantial difference in the buy and sell price. Leveraged products such as Contracts for Difference (CFDs), derivatives, commodities & Foreign Exchange (FX), carry a higher risk to your capital and they can lose their value rapidly.
We advise you to read any literature we provide carefully before making any investment decisions.
Copyright 2023 Collins Sarri Statham Investments Ltd.
Collins Sarri Statham Investments Ltd. is authorised and regulated by the Financial Conduct Authority No. 483868
Registered in England and Wales Company No. 6539190 LEI - 549300OPUKN7OQ6WAX33